ABSolu: new A/B/S/UBM ultrasound platform

ABSolu: new A/B/S/UBM ultrasound platform

ABSolu: new A/B/S/UBM ultrasound platform

Quantel Medical today announced the launch of the new ABSolu® ultrasound platform at the 36th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS 2018) in Vienna, Austria September 22-26.

Combination of leading edge technologies, this A/B/S/UBM ultrasound platform provides unparalleled image quality with an exceptional level of detail.

Technological breakthroughs in the ABSolu® include:

  • A new 5 ring annular technology 20MHz B probe that increases the depth of field by 70% thus offering in a single scan high definition information of the vitreous, retinal wall and orbit.
  • Motion sensors have been integrated in all B Mode and UBM probes allowing for an automatic and constant detection of the probe position and ultrasound beam direction (patented technology).
  • A new signal processing for the linear 50 MHz UBM for to offer high image quality of the anterior chamber and lens.
  • A new full HD screen compliant with section 14 of the DICOM standard, a world premiere in ophthalmic ultrasound.

ABSolu® is our new ultrasound platform replacing our flagship ultrasound system Aviso. It is the achievement of years of work carried out by our R&D Department in collaboration with ultrasound specialists and we can say that once again, we are setting new standards in ophthalmic ultrasound imaging. For ophthalmologists looking for excellence in ultrasound imaging, ABSolu® is the ideal partner in their everyday practice

ESCRS attendees can see the new generation ABSolu® ultrasound platform on the booth #B103.

For more information about ABSolu®, visit our website for healthcare professionnals:
The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at rgpd@lumibirdmedical.com.
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.